Zhengxiong Li
3PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 10, 2025
Cost-effectiveness of sugemalimab plus chemotherapy as first-line therapy in advanced gastric cancer and gastroesophageal junction cancer.Jiaming Zhu, Zhengxiong Li, Qiaoping Xu
|Dec 01, 2025
Cost-effectiveness analysis of anlotinib plus penpulimab versus sorafenib in the treatment of unresectable hepatocellular carcinoma.Jiefeng Luo, Zhengxiong Li, Chengxia Gui
|Aug 28, 2025
Cost-effectiveness of talazoparib plus enzalutamide as first-line therapy in metastatic castration-resistant prostate cancer.Jiaming Zhu, Zhengxiong Li, Ye Ding
Pageof 1
